[Federal Register Volume 78, Number 135 (Monday, July 15, 2013)]
[Notices]
[Page 42088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-16823]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-0001]
Anesthetic and Analgesic Drug Products Advisory Committee;
Cancellation
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The meeting of the Anesthetic and Analgesic Drug Products
Advisory Committee scheduled for July 17, 2013, is cancelled. This
meeting was announced in the Federal Register of May 17, 2013 (78 FR
29142 to 29143). This meeting has been canceled due to new information
submitted to the application. The Agency intends to continue evaluating
the application and, as needed, will announce future meeting dates in
the Federal Register.
FOR FURTHER INFORMATION CONTACT: Caleb Briggs, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001, FAX: 301-847-8533, email: [email protected], or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), and follow the prompts to the desired center or
product area. Please call the Information Line for up-to-date
information on this meeting.
Dated: July 9, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-16823 Filed 7-12-13; 8:45 am]
BILLING CODE 4160-01-P